Mind Medicine (MMED.NE, MNMD.Q) announced that J.R. Rahn is stepping down from his roles as CEO and director. Rahn was a co-founder of the company and was at the…
new CEO
In 25% of Breast Lumpectomy surgeries, cancerous material is left behind.
With current technology, the surgeon needs to wait about a week, to see if he’s got all the cancerous…
No need to cut the patient open again later. The surgeon can make adjustments on the fly….
PINK is accelerating toward the commercialisation of the OTIS platform. It has already received a $7.4 million grant (non-dilutive capital) from the Cancer Prevention and Research Institute of Texas…